Senior Director, Head of Medical Evidence Generation

Position Summary

The Senior Director, Head of Medical Evidence reports into the Vice President, Head of Disease Areas and coordinates with Medical Affairs and cross-functional stakeholders to lead the Integrated Evidence Generation Plans (IEGP) for all marketed products and oversees the design and implementation of Medical Affairs evidence generation projects in alignment with GxP and business strategy.

Main Responsibilities and Accountabilities

• Responsible for oversight and delivery of the strategic integrated evidence generation plans (IEGPs) across therapeutic areas for pipeline and marketed medicines. This includes development, execution, and maintenance of data gap generation and analysis and governance and documentation of all IEGPs.

• Oversee design and implementation of Medical Affairs-led real-world evidence (RWE), epidemiological studies, HEOR, patient preference, and non-interventional studies. Guide development of phase IIIb/IV trials, registries, and observational studies. Ensure quality and timely delivery of study protocols, statistical analysis plans, and reports.

• Anticipate evidence gaps and proactively adjust tactical plans to serve the data needs of key stakeholders, including Regulatory authorities, HTAs, HCPs, and payers.

• Ensure all activities comply with GCP, regulatory standards, and internal policies. Manage budgets, timelines, and vendor relationships. Monitor and report on the impact of evidence generation activities.

• Oversees study tracking of all ongoing Medical Affairs evidence generation projects globally and provides regular reporting to Medical Affairs, including LT, MAST, DA leads.

• Enhance Medical Affairs capabilities in lifecycle management and phase 3b evidence generation.

• Partner with Global Program Teams, Medical Affairs, Clinical Development, Regulatory, and Market Access. Lead or contribute to matrix teams and evidence generation sub-teams. Provides subject matter expertise and consultation to Medical Affairs colleagues in study development and design and interact, as required, with external research partners including investigators and vendors (including but not limited to CROs, database owners, registries, et). Provide support to Medical Disease Area teams for study execution as required.

Qualifications

Education:

• Advanced degree (MS/PhD/PharmD) with relevant scientific/medical background

Experience:

• Minimum of 12 years in pharmaceutical/biopharmaceutical industry inclusive of Medical Affairs.

• 8+ years’ experience in research related experience and/or pharmaceutical industry experience.

• Experience with late-stage clinical studies, research collaborations and RWE Proven track record of strong leadership, project management and demonstrated ability to coach and mentor individuals.

• Strong Regulatory and medical information communications knowledge and experience.

• Ability to communicate and interact thoughtfully, transparently, and appropriately with a variety of stakeholders both internal and external.

• Experience building and leading cross-functional team in a global matrix organization.

Competencies:

• Analytical thinking

• Business acumen

• Customer focus

• Communication clarity

• Emotional Intelligence (EQ)

• Perseverance

• Presentation expertise

• Priority setting

• Scientific expertise

The expected base salary range for this position at hiring is $303,000 - $371,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position in Waltham, MA as of the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

#LI-Hybrid

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.

CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .

Our Benefits